MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
1.500
-0.080
-5.06%
After Hours: 1.500 0 0.00% 19:34 08/12 EDT
OPEN
1.540
PREV CLOSE
1.580
HIGH
1.580
LOW
1.430
VOLUME
16.22K
TURNOVER
--
52 WEEK HIGH
59.40
52 WEEK LOW
1.020
MARKET CAP
1.54M
P/E (TTM)
-38.2653
1D
5D
1M
3M
1Y
5Y
1D
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
Seeking Alpha · 2d ago
Weekly Report: what happened at BDRX last week (0803-0807)?
Weekly Report · 2d ago
Weekly Report: what happened at BDRX last week (0727-0731)?
Weekly Report · 08/03 09:55
Biodexa Pharmaceuticals Restructures Share Capital and Boosts Issuance Capacity After July 29 General Meeting
TipRanks · 07/29 21:13
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 07/29 21:06
Result of General Meeting
Barchart · 07/29 15:30
Biodexa Pharmaceuticals Holds First Round Table Meeting In France To Expand Support For Familial Adenomatous Polyposis Patients, Prescribers
Benzinga · 07/29 12:34
Weekly Report: what happened at BDRX last week (0720-0724)?
Weekly Report · 07/27 09:58
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.